Agenda

Return

C. 58

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	December 14, 2021

Contra

Costa

County

Subject:

Amendment to Purchase Order with Central Admixture Pharmacy Services, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 12/14/2021

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

ABSENT:

Diane Burgis, District III Supervisor

Contact:	Jaspreet Benepal, 925-370-5101
cc:	Irene Segovia Marcy Wilhelm

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: December 14, 2021
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

Approve and authorize the Purchasing Agent to execute, on behalf of the Health Services Department, an amendment to Purchase Order #21052 with Central Admixture Pharmacy Services, Inc. to increase the payment limit by $61,000 for a new payment limit of $260,000 for the compounding of Total Parenteral Nutrition (TPN) and Peripheral Parenteral Nutrition (PPN) intravenous (IV) solutions, with no change in the original term of December 1, 2020 through November 30, 2021.

FISCAL IMPACT:

Approval of this amendment will result in expenditures of up to $260,000 for IV TPN and PPN solutions and is 100% funded in the Hospital Enterprise Fund I budget.

BACKGROUND:

Contra Costa Regional Medical Center's Inpatient Pharmacy has been using Central Admixture Pharmacy Services, Inc. for IV services since May 2005. TPN and PPN, as well as certain IV medications are outsourced. These critical medications products are not made in the Inpatient Pharmacy due to the volume needed. Central Admixture Pharmacy Services, Inc. follows all federal and state sterility laws.

CONSEQUENCE OF NEGATIVE ACTION:

If this amendment is not approved, the lack of products such as TPN’s and PPN’s as well as various IV solution compounds, needed for treating patients will be unavailable, causing a negative impact in the health of our patients at Contra Costa Regional Medical Center.